Temple University Hospital - 3401 N Broad St- Site Number : 130 — Philadelphia, Pennsylvania

Temple University Hospital - 3401 N Broad St- Site Number : 130 is a clinical research site located in Philadelphia, Pennsylvania, United States 19140-5103.

Crixeo Clinical Trials Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

Temple University Hospital - 3401 N Broad St- Site Number : 130 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Alpha 1-Antitrypsin Deficiency, Emphysema.

Sponsors: Sanofi.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Philadelphia

Browse all research sites in Pennsylvania · View every site in Philadelphia

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Temple University Hospital - 3401 N Broad St- Site Number : 130?

Temple University Hospital - 3401 N Broad St- Site Number : 130 has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Temple University Hospital - 3401 N Broad St- Site Number : 130 conducted?

Temple University Hospital - 3401 N Broad St- Site Number : 130 has 1 clinical trials on record, with 1 currently active. Their work covers Alpha 1-Antitrypsin Deficiency, Emphysema.

Is Temple University Hospital - 3401 N Broad St- Site Number : 130 accredited by Crixeo Clinical Trials?

Temple University Hospital - 3401 N Broad St- Site Number : 130 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Temple University Hospital - 3401 N Broad St- Site Number : 130?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.